Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Personalized medicine: moving from simple theory to daily practice
4. Evaluating and using innovative technologies: a lesson from Theranos?
5. Review
6. Emerging biomarkers in the detection and prognosis of prostate cancer
7. Mini Review
8. Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale
9. Opinion Papers
10. Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe
11. Theranos phenomenon: promises and fallacies
12. Clinical laboratories: production industry or medical services?
13. Genetics and Molecular Diagnostics
14. Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
15. Direct identification of Gram-positive bacteria and resistance determinants from blood cultures using a microarray-based nucleic acid assay: in-depth analysis of microarray data for undetermined results
16. General Clinical Chemistry and Laboratory Medicine
17. Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty
18. Role of vitamin D and sFlt-1/PlGF ratio in the development of early- and late-onset preeclampsia
19. Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult
20. PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer’s disease or vascular dementia
21. Comparison of five automated hematology analyzers in a university hospital setting: Abbott Cell-Dyn Sapphire, Beckman Coulter DxH 800, Siemens Advia 2120i, Sysmex XE-5000, and Sysmex XN-2000
22. Dacryocytes are a common morphologic feature of autoimmune and microangiopathic haemolytic anaemia
23. Performance characteristics of a new automated method for measurement of anti-cyclic citrullinated peptide
24. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β₂ glycoprotein I antibodies. A comparison with a homemade ELISA method
25. Reference Values and Biological Variations
26. Reference interval for immature platelet fraction on Sysmex XN hematology analyzer: a comparison study with Sysmex XE-2100
27. Development of the first urinary reproductive hormone ranges referenced to independently determined ovulation day
28. Cancer Diagnostics
29. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue
30. Cardiovascular Diseases
31. Elevated circulating levels of lipoprotein-associated phospholipase A₂ in obese children
32. Letters to the Editors
33. Reporting of hemolysis index (HI) with laboratory results should be obligatory in newborns and infants
34. Unmeasurably high chloride: a surrogate marker of thiocyanate poisoning identification
35. Association between red cell distribution width and myocardial infarction in rheumatoid arthritis
36. Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency
37. Rapid diagnosis of cryptococcal meningitis by Türk staining
38. A high selectivity and sensitivity analytical method for the analysis of 8-hydroxy-2′-deoxyguanosine in the urine of Alzheimer’s disease patients
39. S100B protein concentration measurement according to two different immunoassays